Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 1.84 USD
Market Cap: 2.4m USD

Intrinsic Value

RDHL doesn't have a meaningful market cap.
RDHL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one RDHL stock under the Base Case scenario is 13.17 USD. Compared to the current market price of 1.84 USD, Redhill Biopharma Ltd is Undervalued by 86%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RDHL Intrinsic Value
13.17 USD
Undervaluation 86%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Redhill Biopharma Ltd

Valuation History Unavailable

Historical valuation for RDHL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Redhill Biopharma Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Redhill Biopharma Ltd

Current Assets 11.9m
Cash & Short-Term Investments 4.6m
Receivables 2.5m
Other Current Assets 4.8m
Non-Current Assets 6.1m
PP&E 437k
Intangibles 5.5m
Other Non-Current Assets 148k
Efficiency

Free Cash Flow Analysis
Redhill Biopharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Redhill Biopharma Ltd

Revenue
8m USD
Cost of Revenue
-3.2m USD
Gross Profit
4.9m USD
Operating Expenses
-19.5m USD
Operating Income
-14.6m USD
Other Expenses
6.3m USD
Net Income
-8.3m USD
Fundamental Scores

RDHL Profitability Score
Profitability Due Diligence

Redhill Biopharma Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional ROE
Positive 3-Year Average ROE
ROE is Increasing
34/100
Profitability
Score

Redhill Biopharma Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

RDHL Solvency Score
Solvency Due Diligence

Redhill Biopharma Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
37/100
Solvency
Score

Redhill Biopharma Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RDHL Price Targets Summary
Redhill Biopharma Ltd

There are no price targets for RDHL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Redhill Biopharma Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for RDHL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one RDHL stock?

The intrinsic value of one RDHL stock under the Base Case scenario is 13.17 USD.

Is RDHL stock undervalued or overvalued?

Compared to the current market price of 1.84 USD, Redhill Biopharma Ltd is Undervalued by 86%.

Back to Top